Escitalopram Impurity 10 | CAS 260371-16-2 - Request Quote
Escitalopram Impurity 10
| SZ CAT No: | SZ-E002060 |
| CAS No | 260371-16-2 |
| Mol.F. | C15H10FNO2 |
| Mol.Wt. | 255.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Escitalopram Impurity 10 is chemically 4-(4-Fluorobenzoyl)-3-(hydroxymethyl)benzonitrile. Escitalopram Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Escitalopram Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Escitalopram.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 260371-16-2
Purchase 260371-16-2
Order 260371-16-2
Enquire 260371-16-2
price of 260371-16-2
260371-16-2 Supplier
260371-16-2 Manufacturer
260371-16-2 Exporter
buy high quality Escitalopram Impurity 10
Purchase Escitalopram Impurity 10
Escitalopram Impurity 10 suppliers
Escitalopram Impurity 10 manufacturers
Escitalopram Impurity 10 price
Order Escitalopram Impurity 10
Enquire Escitalopram Impurity 10
Escitalopram Impurity 10 cost
Escitalopram Impurity 10 Supplier
Escitalopram Impurity 10 Distributor
Escitalopram Impurity 10 for Method Validation
Escitalopram Reference Standard
Escitalopram Impurity 10 for ANDA Filing
Escitalopram Impurity 10 for Forced Degradation Studies
Escitalopram Impurity 10 Identification Standards
Escitalopram Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


